CeQur Archives - Medical Design Sourcing

6 drug delivery innovations you need to know

From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops.

Vaccines, life-saving therapeutics, vision-correcting drugs and more are being developed and marketed for delivery with all kinds of technologies.

More than a year ago, we compiled a list of eight drug delivery innovations you need to know. With some updates on some of those technologies, plus introductions to others, here are some more impressive developments you should keep an eye on:

1. Needle-free delivery

Vaccines have become a major talking point over the past couple of years amid the COVID-19 pandemic and a number of companies are working on ways to deliver them, as well as other forms of medication, through different avenues.

A major speed bump in vaccine hesitancy can be fear of needles, so the introduction of needle-free drug delivery could make big waves in the space.

Two companies pushing forward with …

CeQur is launching a discreet, convenient ‘wearable insulin pen’

The CeQur Simplicity wearable insulin delivery device. [Image courtesy of CeQur] CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes.

When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that.

Simplicity, a wearable, disposable bolus insulin delivery system, was developed as, essentially, a wearable insulin pen. CeQur began a pilot commercial launch for the FDA-cleared and CE-marked device in early 2021, which concluded just last month, and now the company is entering the next phase of a limited market release. In April of last year, the company raised $115 to support that launch and scale up manufacturing.

For those on the receiving end of the launch, CeQur CEO Brad Paddock said virtually nothing changes.

“They manage it however they were before,” P…

CeQur raises $115M for wearable insulin delivery device

CeQur announced today that it closed an oversubscribed equity financing round with proceeds of $115 million.

Lucerne, Switzerland/Marlborough, Mass.–based CeQur said in a news release that it plans to use the funds to advance the commercial plans for the CeQur Simplicity wearable insulin delivery device. The company’s plans include market development, a phased commercial launch with a limited market release in 2021 and the scale-up of high-volume manufacturing.

Get the full story at our sister site, Drug Delivery Business News.